UBS Reiterates Buy Rating on Lam Research
UBS analyst Timothy Arcuri reiterated a Buy rating and $310.00 price target on Lam Research (NASDAQ: LRCX).
“After many years of SPE being driven mostly by growth from China, LRCX is finally embarking on the AI-fueled supercycle – much like we have seen with NVDA/AVGO and memory makers over the past few years and Street numbers here should start to inflect considerably higher.
WFE is still constrained this year by a lack of new cleanroom, but LRCX still tweaked WFE a bit higher and now in-line w/ our model.
From here, we see sufficient demand for WFE to approach $190-200B next year and we were encouraged by LRCX’s commentary about how business is lining up – especially with mega-projects like Terafab (via INTC, we think) now taking shape.
Unless memory revenue totally collapses in C2028 – which seems very unlikely – semiconductor revenue should hold ~$2T+, a level that can easily support WFE in the ~$240-250B range, though this may depend to some degree on equipment supply.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
